HEALWELL AI to Announce Fiscal Third Quarter 2025 Financial Results on November 6, 2025October 27, 2025 5:08 PM EDT | Source: HEALWELL AIHEALWELL AI to announce third quarter 2025 financial results on Thursday November 6, 2025, and hold a conference call with simultaneous webcast on Friday, November 7, 2025, at 8:30 am ET (5:30 am PT). Toronto, Ontario--(Newsfile Corp. - October 27, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intel ...

Core Insights - HEALWELL AI Inc. has filed an amended and restated business acquisition report regarding its acquisition of Orion Health Holdings Limited, which was completed on April 1, 2025 [1][2] - The amended report updates the audit report to confirm compliance with International Standards on Auditing (ISA) instead of the previously reported ISA (New Zealand) [2] Company Overview - HEALWELL AI is a healthcare artificial intelligence company focused on preventative care, aiming to improve healthcare through early disease identification and detection [4] - The company is developing advanced clinical decision support systems to assist healthcare providers in detecting rare and chronic diseases, enhancing practice efficiency, and improving patient health outcomes [4] - HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF" [4]

Core Insights - HEALWELL AI's DARWEN™ AI Platform is one of the first to generate regulatory-grade real-world data (RWD) to enhance patient access and advance the pharmaceutical industry [3][4][6] - The collaboration with Takeda Pharmaceutical showcased the platform's ability to improve remission outcomes in ulcerative colitis and Crohn's disease through vedolizumab dose escalation [4][6] - HEALWELL's unique AI-driven RWD generation capability is expected to significantly impact clinical and commercial value in healthcare [3][6] Company Overview - HEALWELL AI Inc. focuses on preventative care using artificial intelligence to improve healthcare outcomes through early disease detection [9] - The company is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under "HWAIF" [9] - HEALWELL has been recognized for its leadership in healthcare AI, being named a finalist in Newsweek's AI Impact Awards 2025 [7][8] Industry Impact - The use of AI in generating RWD is a transformative approach that can lead to more precise and effective patient-centered care [5][6] - The platform's ability to extract clinically meaningful insights from electronic health records positions HEALWELL at the forefront of healthcare AI innovation [5][6] - The advancements in RWD generation are expected to facilitate faster and more accurate development of pharmaceutical products, ultimately improving patient outcomes [5][6]

Core Viewpoint - HEALWELL AI Inc. is set to announce its Fiscal Second Quarter 2025 financial results on August 13, 2025, and will hold a conference call to discuss these results [1][2]. Company Overview - HEALWELL AI is a healthcare artificial intelligence company focused on preventative care, aiming to improve healthcare and save lives through early disease identification and detection [3]. - The company is developing advanced clinical decision support systems to assist healthcare providers in detecting rare and chronic diseases, enhancing practice efficiency, and improving patient health outcomes [3]. - HEALWELL AI is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF" [3].

Core Insights - HEALWELL AI Inc. has reported improved performance in its AI business units, with a focus on preventative care and the acquisition of the remaining interest in Pentavere Research Group Inc. [2][6] - The AI business segment is projected to exceed $5 million in revenues for the first half of 2025, marking a year-over-year increase of over 200% [3][6] Financial Performance - Preliminary revenues for the AI business segment are expected to surpass $5 million for the first six months of 2025, indicating a significant growth compared to the previous year [3][6] - Positive Adjusted EBITDA is anticipated for the AI business segment during the same period [3][6] Strategic Developments - HEALWELL has acquired the remaining 49% of Pentavere, achieving full ownership, which is expected to enhance integration within its AI business segment [6][11] - The acquisition was completed for an aggregate purchase price of approximately $13.98 million, satisfied through the issuance of shares [11] Leadership and Vision - James Lee, the new CEO, expressed confidence in the potential of the AI division and highlighted the opportunity to differentiate offerings and accelerate commercialization of AI products [5][10] - The company aims to integrate its AI and data science products into its software platforms to facilitate market adoption [8] Product and Market Focus - Pentavere's DARWEN™ platform is recognized for its role in patient identification and preventative care, validated by major healthcare systems [9][10] - The company emphasizes the urgent need for AI in healthcare to address challenges faced by global healthcare systems [10]